Journal: Translational Cancer Research
Article Title: Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma
doi: 10.21037/tcr-22-2651
Figure Lengend Snippet: Gene expression of MT2A after supplementation of different zinc concentrations. The data were measured 77 h after supplementation of zinc. The difference in MT2A expression of the sample between zinc-treatment and control is shown on the y-axis (2 −ΔCp ) (Cp means the crossing point describing the cycle at which the fluorescence first rises significantly above the background fluorescence). All MPM cell lines showed elevated expression of MT2A by adding higher concentrations of zinc [(A) MSTO211H (P=0.0833), (B) NCI-H2452 (P=1), and (C) NCI-H2052 (P=0.0833)]. P values were calculated by using the Spearman’s rank correlation test. MT2A , metallothionein IIA; MPM, malignant pleural mesothelioma.
Article Snippet: All MPM cell lines [NCI-H2052: CRL-5915; NCI-H2452: CRL-5946; MSTO-211H: CRL-2081; American Type Culture Collection (ATCC), Virginia, USA] were cultured in Roswell Park Memorial Institute 1640 medium (RPMI) (Thermo Fisher Scientific, Massachusetts, USA), supplemented with 10% fetal calf serum (FCS) and 1% penicillin and streptomycin (P/S, Thermo Fisher Scientific, Massachusetts, USA).
Techniques: Gene Expression, Expressing, Control, Fluorescence